Behavior and the Response of Cancer Cells on Anticancer Drug Treatment Monitored with Microelectrode Array  by Anh-Nguyen, T. et al.
 Procedia Engineering  120 ( 2015 )  928 – 931 
1877-7058 © 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of the organizing committee of EUROSENSORS 2015
doi: 10.1016/j.proeng.2015.08.801 
ScienceDirect
Available online at www.sciencedirect.com
 
EUROSENSORS 2015 
Behavior and the response of cancer cells on anticancer drug 
treatment monitored with microelectrode array 
T.Anh-Nguyena, D. T. Tranb, U. Pliquettc and G. A. Urbana 
aDepartment of Microsystems Engineering-IMTEK, University of Freiburg, Germany 
bVNU University of Engineering and Technology, Ha Noi, Viet Nam 
cInstitute for Bioprocessing and Analytical Measurement Techniques e.V, Heiligenastadt, Germany 
Abstract 
A cell-based impedance biosensor using microelectrode array has been developed for monitoring cellular activities 
of MCF-7 breast cancer cells and evaluating drug-induced apoptosis. Using this device, different activities of cells 
such as cell attachment, adhesion, and spreading are monitored by measuring impedance spectra and interpreting the 
data using an electrical equivalent circuit. In order to demonstrate pharmaceutical relevance, the cells were treated 
with 25 μM of anti-cancer drug Cisplatin. It was found that cell spreading caused a significant increase of 
impedance magnitude in the frequency range between 10 kHz and 100 kHz during 23 h of incubation, which is 
reversed after 24 h treatment with Cisplatin. This reversal is attributed to cell apoptosis, which is confirmed by 
microscopic observation of the cells.  
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1. Introduction 
Different label-free and non-invasive tools such as cell-substrate impedance [1], quartz microbalance [2] and field-
effect transistor [3] have been developed for in vitro cellular studies in the last three decades. Real-time and kinetic 
information of cell behaviors can be measured using those devices. Among them, Cell-based Impedance Biosensor 
(CIB) has emerged as a powerful tool for investigating various cellular events. Cell attachment, spreading, and 
proliferation can be monitored by measuring electrical alternations at the interfaces between the cell and the 
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electrode [4, 5]. Recently, the CIBs have gained greater attention to studying cancer cells and monitoring drug-
induced cellular events for pharma-screening [1, 6]. 
In this work, we present an impedance cell-based biosensor which can be used for long term monitoring of cell 
attachment, adhesion and spreading of MCF-7 breast cancer cells on the microelectrode surface which are in square 
of 60 μm2. We focused on the response of cells to the anti-cancer drug Cisplatin treatment.  
2. Chip design and fabrication process 
2.1. Chip design 
The design of the biosensor chip is illustrated in Fig.1, which consists of two main parts: microelectrode arrays 
(MEAs) and a small cylindrical well. The MEAs are composed of four columns in which each column consists of 
eight square microelectrodes (60 μm2). These electrodes are arranged symmetrically to a big rectangular counter 
electrode (350u 1500 μm2) in the center. The counter electrode is large with respect to the working electrode. A 
small well with 6 mm in diameter and a height of 7 mm was glued on the substrate as the reservoir for cell culture 
medium. 
 
 
 
 
 
 
 
 
 
 
  (a)      (b)  
Fig. 1: (a) Design of the biosensor which consists of two main parts: MEAs and a small well. (b) An image of a packaged biosensor with cell 
culture medium inside the well. 
2.2. Fabrication process 
The chips were fabricated based on standard microfabrication techniques. The metal films Cr/Au/Ti (10/200/50 nm) 
were deposited on a Pyrex wafer using an electron-beam evaporator (PVD). Then, the MEAs, bonding pads and 
connecting lines were patterned by using the lift-off process. Next, a passivation layer was deposited using plasma 
enhanced chemical vapour deposition (PECVD). Thereafter, photolithography and dry etching using reactive ion 
etching (RIE) were subsequently performed to open the MEAs and the bonding pad regions. The Au 
microelectrodes were formed by using a wet-etching process to remove the Ti protection layer. Finally, a small 
cylindrical well was glued on the substrate using biocompatible epoxy. 
2.3. Experimental procedure 
The chips were used to perform experiments after cleaning, packaging, wire bonding, and sterilization processes. 
The Au microelectrode surfaces were modified by physical absorption of Fibronectin (Sigma-Aldrich) with 
concentration of 20 μg/mL, which enhance the cell adhesion process. Then, 100 μL of cell suspension with low 
concentration of ͳʹ ൈ ͳͲଷ cells/mL was injected into the chips and incubated. Next, the impedance measurement 
was carried out after cell seeding for 4, 6, and 23 h to monitor the cell attachment and spreading process. Thereafter, 
the medium was replaced by 25 μM of Cisplatin to monitor the response of cells. 
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3. Results and discussion 
3.1. Monitor cell attachment and spreading 
Fig. 2 (a) illustrates the impedance magnitude change corresponding different incubation times. The result is 
expected because after incubating cells for 6 h (red line), the adhesion level and the cell morphology did not 
dramatically change in comparison with 4 h (black line) which in turn not yield further impedance increase. In 
contrast, the impedance magnitude significantly increases over the entire frequency range after incubating cells for 
nearly 1 day (blue line). This is mostly attributed to spreading of the cells on the substrate which increases not only 
the electrode coverage but also the level of cell attachment to the electrode surface.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: (a) Mean (n=20) impedance magnitudes after culturing cells for 4, 6, and 23 h. (b) Magnified portion of figure (a) in the frequency range 
from 10 to 100 kHz along with signals from reference electrodes 
 
The difference of impedance spectra at 4 h and 6 h is rather small in Fig. 2 (a). Therefore, the frequency range 
between 10 kHz and 100 kHz is zoomed as shown in Fig. 2 (b) along with signals from reference microelectrodes 
without cells (magenta line).  Due to the presence of cells, the impedance at different incubation times is higher 
compared with the baseline signal of reference microelectrode. 
3.2. Monitor drug-induced apoptosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The impedance spectra (Bode plot) measured on working electrodes with cancer cells after exposing on 25 μM Cisplatin for 0, 4, 7, 
and 23h. 
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The response of MCF-7 breast cancer cells to 25 μM of anti-cancer drug Cisplatin is a drop of impedance magnitude 
as shown in Fig.3. The first measurement (at 0 h) was performed immediately after replacing the cell culture 
medium inside the well by Cisplatin. The shape of this curve (black line) is similar to the curve after 23 h of 
incubation in drug-free medium in Fig. 2 (a) because cells did not have enough time to relax after physiological 
condition changed. As obvious, the decrease of impedance magnitude depends on the different exposure times (red, 
blue and magenta lines). 
4. Conclusions 
We demonstrate a cell-based impedance biosensor for label-free monitoring the culture activities of MCF-7 breast 
cancer cells and we evaluated the response of them to anti-cancer drug Cisplatin treatment. The impedance spectra 
indicate that the cellular activities such as cell attachment and spreading can be monitored using this device. 
Especially, the responses of MCF-7 cells to Cisplatin were successfully monitored. Our ECIS biosensor opens-up a 
wide range of applications in cell biology or preclinical testing of established and discovery of new anti-cancer 
drugs.  
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